Spotlight
Ionis Antisense Programs Highlighted at the OTS Annual Meeting
More »
SPINRAZA: An Exemplary Development Path for Gene Therapies to Follow
More »
Newly Published Preclinical Data Demonstrate the Potential of IONIS-KRAS-2.5Rx in Cancer
More »
Nature Communications Publishes Preclinical Results Evaluating Antisense Drugs Targeting DNM2 for the Treatment of Centronuclear Myopathy
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
